Annual D&A
$628.00 K
+$9000.00+1.45%
01 December 2023
Summary:
Plus Therapeutics annual depreciation & amortization is currently $628.00 thousand, with the most recent change of +$9000.00 (+1.45%) on 01 December 2023. During the last 3 years, it has risen by +$262.00 thousand (+71.58%). PSTV annual D&A is now -70.80% below its all-time high of $2.15 million, reached on 31 December 2017.PSTV Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$232.00 K
+$30.00 K+14.85%
01 September 2024
Summary:
Plus Therapeutics quarterly depreciation & amortization is currently $232.00 thousand, with the most recent change of +$30.00 thousand (+14.85%) on 01 September 2024. Over the past year, it has increased by +$167.00 thousand (+256.92%). PSTV quarterly D&A is now -62.34% below its all-time high of $616.00 thousand, reached on 30 June 2006.PSTV Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$685.00 K
+$44.00 K+6.86%
01 September 2024
Summary:
Plus Therapeutics TTM depreciation & amortization is currently $685.00 thousand, with the most recent change of +$44.00 thousand (+6.86%) on 01 September 2024. Over the past year, it has increased by +$57.00 thousand (+9.08%). PSTV TTM D&A is now -68.95% below its all-time high of $2.21 million, reached on 31 March 2018.PSTV TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +256.9% | +9.1% |
| 3 y3 years | +71.6% | +166.7% | +90.8% |
| 5 y5 years | -68.7% | +44.1% | -48.0% |
PSTV Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +71.6% | at high | +256.9% | -1.0% | +90.8% |
| 5 y | 5 years | -68.7% | +71.6% | at high | +256.9% | -48.0% | +91.9% |
| alltime | all time | -70.8% | +71.6% | -62.3% | +148.5% | -69.0% | +94.0% |
Plus Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $232.00 K(+14.9%) | $685.00 K(+6.9%) |
| June 2024 | - | $202.00 K(+8.6%) | $641.00 K(+2.2%) |
| Mar 2024 | - | $186.00 K(+186.2%) | $627.00 K(-0.2%) |
| Dec 2023 | $628.00 K(+1.5%) | $65.00 K(-65.4%) | $628.00 K(-4.3%) |
| Sept 2023 | - | $188.00 K(0.0%) | $656.00 K(-5.2%) |
| June 2023 | - | $188.00 K(+0.5%) | $692.00 K(+9.1%) |
| Mar 2023 | - | $187.00 K(+101.1%) | $634.00 K(+2.4%) |
| Dec 2022 | $619.00 K(+56.7%) | $93.00 K(-58.5%) | $619.00 K(-5.5%) |
| Sept 2022 | - | $224.00 K(+72.3%) | $655.00 K(+26.4%) |
| June 2022 | - | $130.00 K(-24.4%) | $518.00 K(+8.1%) |
| Mar 2022 | - | $172.00 K(+33.3%) | $479.00 K(+21.3%) |
| Dec 2021 | $395.00 K(+7.9%) | $129.00 K(+48.3%) | $395.00 K(+10.0%) |
| Sept 2021 | - | $87.00 K(-4.4%) | $359.00 K(+0.6%) |
| June 2021 | - | $91.00 K(+3.4%) | $357.00 K(-0.8%) |
| Mar 2021 | - | $88.00 K(-5.4%) | $360.00 K(-1.6%) |
| Dec 2020 | $366.00 K(-59.2%) | $93.00 K(+9.4%) | $366.00 K(-6.4%) |
| Sept 2020 | - | $85.00 K(-9.6%) | $391.00 K(-16.3%) |
| June 2020 | - | $94.00 K(0.0%) | $467.00 K(-14.6%) |
| Mar 2020 | - | $94.00 K(-20.3%) | $547.00 K(-39.0%) |
| Dec 2019 | $896.00 K(-55.3%) | $118.00 K(-26.7%) | $896.00 K(-32.0%) |
| Sept 2019 | - | $161.00 K(-7.5%) | $1.32 M(-20.0%) |
| June 2019 | - | $174.00 K(-60.7%) | $1.65 M(-15.6%) |
| Mar 2019 | - | $443.00 K(-17.8%) | $1.95 M(-2.7%) |
| Dec 2018 | $2.00 M(-6.8%) | $539.00 K(+10.0%) | $2.00 M(+0.3%) |
| Sept 2018 | - | $490.00 K(+2.5%) | $2.00 M(-3.7%) |
| June 2018 | - | $478.00 K(-3.8%) | $2.07 M(-6.0%) |
| Mar 2018 | - | $497.00 K(-6.8%) | $2.21 M(+2.6%) |
| Dec 2017 | $2.15 M(+82.0%) | $533.00 K(-5.8%) | $2.15 M(+7.2%) |
| Sept 2017 | - | $566.00 K(-7.2%) | $2.01 M(+20.8%) |
| June 2017 | - | $610.00 K(+38.0%) | $1.66 M(+24.5%) |
| Mar 2017 | - | $442.00 K(+13.9%) | $1.33 M(+12.8%) |
| Dec 2016 | $1.18 M(+8.1%) | $388.00 K(+76.4%) | $1.18 M(+5.0%) |
| Sept 2016 | - | $220.00 K(-22.3%) | $1.13 M(-2.7%) |
| June 2016 | - | $283.00 K(-2.7%) | $1.16 M(-1.2%) |
| Mar 2016 | - | $291.00 K(-12.3%) | $1.17 M(+7.1%) |
| Dec 2015 | $1.09 M(+40.3%) | $332.00 K(+32.3%) | $1.09 M(+7.7%) |
| Sept 2015 | - | $251.00 K(-15.5%) | $1.01 M(+7.4%) |
| June 2015 | - | $297.00 K(+39.4%) | $945.00 K(+13.6%) |
| Mar 2015 | - | $213.00 K(-16.1%) | $832.00 K(+6.8%) |
| Dec 2014 | $779.00 K(-52.2%) | $254.00 K(+40.3%) | $779.00 K(-21.0%) |
| Sept 2014 | - | $181.00 K(-1.6%) | $986.00 K(-25.0%) |
| June 2014 | - | $184.00 K(+15.0%) | $1.31 M(-17.4%) |
| Mar 2014 | - | $160.00 K(-65.3%) | $1.59 M(-2.5%) |
| Dec 2013 | $1.63 M | $461.00 K(-9.4%) | $1.63 M(+17.3%) |
| Sept 2013 | - | $509.00 K(+10.7%) | $1.39 M(+21.9%) |
| June 2013 | - | $460.00 K(+130.0%) | $1.14 M(+24.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $200.00 K(-9.5%) | $913.00 K(-2.1%) |
| Dec 2012 | $933.00 K(+9.1%) | $221.00 K(-14.7%) | $933.00 K(-1.4%) |
| Sept 2012 | - | $259.00 K(+11.2%) | $946.00 K(+4.2%) |
| June 2012 | - | $233.00 K(+5.9%) | $908.00 K(+3.1%) |
| Mar 2012 | - | $220.00 K(-6.0%) | $881.00 K(+3.0%) |
| Dec 2011 | $855.00 K(-8.2%) | $234.00 K(+5.9%) | $855.00 K(+9.6%) |
| Sept 2011 | - | $221.00 K(+7.3%) | $780.00 K(+0.3%) |
| June 2011 | - | $206.00 K(+6.2%) | $778.00 K(-8.7%) |
| Mar 2011 | - | $194.00 K(+22.0%) | $852.00 K(-8.5%) |
| Dec 2010 | $931.00 K(-44.6%) | $159.00 K(-27.4%) | $931.00 K(-20.7%) |
| Sept 2010 | - | $219.00 K(-21.8%) | $1.17 M(-13.5%) |
| June 2010 | - | $280.00 K(+2.6%) | $1.36 M(-15.5%) |
| Mar 2010 | - | $273.00 K(-32.1%) | $1.61 M(-4.3%) |
| Dec 2009 | $1.68 M(+9.7%) | $402.00 K(-0.2%) | $1.68 M(+2.0%) |
| Sept 2009 | - | $403.00 K(-24.0%) | $1.65 M(+1.0%) |
| June 2009 | - | $530.00 K(+53.2%) | $1.63 M(+9.8%) |
| Mar 2009 | - | $346.00 K(-6.2%) | $1.49 M(-3.0%) |
| Dec 2008 | $1.53 M(-5.1%) | $369.00 K(-4.7%) | $1.53 M(-1.3%) |
| Sept 2008 | - | $387.00 K(+0.5%) | $1.55 M(+0.2%) |
| June 2008 | - | $385.00 K(-1.8%) | $1.55 M(-3.8%) |
| Mar 2008 | - | $392.00 K(+0.8%) | $1.61 M(-0.3%) |
| Dec 2007 | $1.62 M(-23.8%) | $389.00 K(+1.3%) | $1.62 M(-7.2%) |
| Sept 2007 | - | $384.00 K(-13.9%) | $1.74 M(-5.3%) |
| June 2007 | - | $446.00 K(+12.3%) | $1.84 M(-8.5%) |
| Mar 2007 | - | $397.00 K(-22.9%) | $2.01 M(-5.2%) |
| Dec 2006 | $2.12 M(+23.0%) | $515.00 K(+7.1%) | $2.12 M(+4.0%) |
| Sept 2006 | - | $481.00 K(-21.9%) | $2.04 M(+2.6%) |
| June 2006 | - | $616.00 K(+21.3%) | $1.99 M(+10.0%) |
| Mar 2006 | - | $508.00 K(+17.1%) | $1.81 M(+4.8%) |
| Dec 2005 | $1.72 M(+109.2%) | $434.00 K(+1.2%) | $1.72 M(+112.3%) |
| Sept 2005 | - | $429.00 K(-1.4%) | $812.00 K(-0.9%) |
| June 2005 | - | $435.00 K(+2.1%) | $819.00 K(+0.4%) |
| Mar 2005 | - | $426.00 K(-189.1%) | $816.00 K(-1.0%) |
| Dec 2004 | $824.00 K(-50.3%) | -$478.00 K(-209.6%) | $824.00 K(-52.8%) |
| Sept 2004 | - | $436.00 K(+0.9%) | $1.74 M(+2.5%) |
| June 2004 | - | $432.00 K(-0.5%) | $1.70 M(+0.9%) |
| Mar 2004 | - | $434.00 K(-1.8%) | $1.69 M(+1.7%) |
| Dec 2003 | $1.66 M(+12.6%) | $442.00 K(+12.5%) | $1.66 M(+5.9%) |
| Sept 2003 | - | $393.00 K(-5.5%) | $1.56 M(-0.4%) |
| June 2003 | - | $416.00 K(+2.5%) | $1.57 M(+3.0%) |
| Mar 2003 | - | $406.00 K(+16.3%) | $1.52 M(+3.6%) |
| Dec 2002 | $1.47 M(+24.2%) | $349.00 K(-12.5%) | $1.47 M(+31.1%) |
| Sept 2002 | - | $399.00 K(+7.8%) | $1.12 M(+55.2%) |
| June 2002 | - | $370.00 K(+4.8%) | $723.00 K(+104.8%) |
| Mar 2002 | - | $353.00 K | $353.00 K |
| Dec 2001 | $1.18 M(+168.5%) | - | - |
| Dec 2000 | $441.00 K | - | - |
FAQ
- What is Plus Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Plus Therapeutics?
- What is Plus Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Plus Therapeutics?
- What is Plus Therapeutics quarterly D&A year-on-year change?
- What is Plus Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Plus Therapeutics?
- What is Plus Therapeutics TTM D&A year-on-year change?
What is Plus Therapeutics annual depreciation & amortization?
The current annual D&A of PSTV is $628.00 K
What is the all time high annual D&A for Plus Therapeutics?
Plus Therapeutics all-time high annual depreciation & amortization is $2.15 M
What is Plus Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of PSTV is $232.00 K
What is the all time high quarterly D&A for Plus Therapeutics?
Plus Therapeutics all-time high quarterly depreciation & amortization is $616.00 K
What is Plus Therapeutics quarterly D&A year-on-year change?
Over the past year, PSTV quarterly depreciation & amortization has changed by +$167.00 K (+256.92%)
What is Plus Therapeutics TTM depreciation & amortization?
The current TTM D&A of PSTV is $685.00 K
What is the all time high TTM D&A for Plus Therapeutics?
Plus Therapeutics all-time high TTM depreciation & amortization is $2.21 M
What is Plus Therapeutics TTM D&A year-on-year change?
Over the past year, PSTV TTM depreciation & amortization has changed by +$57.00 K (+9.08%)